mast cell leukemia
Showing 1 - 14 of 14
Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial
Completed
- Aggressive Systemic Mastocytosis
- +3 more
-
Stanford, California
- +10 more
Jan 12, 2023
High-risk MDS, Acute Myelogenous Leukemia, Systemic Mastocytosis Trial in Minneapolis, Madison (GTB-3550 TriKE® Phase I,
Terminated
- High-risk Myelodysplastic Syndromes
- +3 more
- GTB-3550 TriKE® Phase I
- GTB-3550 TriKE® Phase II
-
Minneapolis, Minnesota
- +1 more
Mar 21, 2022
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematologic Tumor
Active, not recruiting
- Advanced Systemic Mastocytosis
- +3 more
-
Stanford, California
- +31 more
Mar 25, 2022
Avapritinib Versus Best Available Therapy in Patients With AdvSM
Completed
- Advanced Systemic Mastocytosis
- +3 more
-
Palo Alto, California
- +5 more
Dec 17, 2021
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematological Tumor
Approved for marketing
- Advanced Systemic Mastocytosis
- +3 more
- (no location specified)
Oct 5, 2021
Acute Undifferentiated Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With
Completed
- Acute Undifferentiated Leukemia
- +10 more
- bioelectric impedance analysis
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jul 30, 2020
Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in
Completed
- Acute Undifferentiated Leukemia
- +63 more
- total-body irradiation
- +7 more
-
Seattle, Washington
- +1 more
Jan 17, 2020
Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic
Completed
- Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
- +76 more
- fludarabine phosphate
- +6 more
-
Tucson, Arizona
- +10 more
Jan 17, 2020
Aggressive Systemic Mastocytosis, Mast Cell Leukemia, Systemic Mastocytosis Trial in Stanford, Houston (Brentuximab vedotin)
Completed
- Aggressive Systemic Mastocytosis
- +2 more
- Brentuximab vedotin
-
Stanford, California
- +1 more
Jan 9, 2019
Aggressive Systemic Mastocytosis, Mast Cell Leukemia, Systemic Mastocytosis Trial in Stanford (Ibrutinib)
Terminated
- Aggressive Systemic Mastocytosis
- +2 more
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Aug 24, 2018
Collecting and Storing Malignant, Borderline Malignant
Completed
- Acute Undifferentiated Leukemia
- +13 more
- Cytology Specimen Collection Procedure
-
Birmingham, Alabama
- +191 more
Jul 17, 2018
Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +178 more
- fludarabine phosphate
- +5 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017
Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +50 more
- Akt inhibitor MK2206
- +2 more
-
Birmingham, Alabama
- +24 more
Apr 28, 2014
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +84 more
- sunitinib malate
- +2 more
-
Los Angeles, California
- +10 more
Mar 14, 2014